We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
We are updating our content for unapproved therapeutic goods. Please give your feedback.
If the product you want to use is on the list and conditions are met, you can access immediately under SAS Category C.
You must notify us within 28 days of use of the unapproved product.
To notify us, submit the form in the online system.
You must meet all listed criteria to prescribe a product. This includes:
- dosage form
- route of administration
- indication
- practitioner type.
There are separate lists for medicines, biologicals and medical devices.
Read more about unapproved products for individual patients (Special Access Scheme).
Medicines
| Active ingredient, dosage form, route of administration | Indication | Practitioner type | Code |
|---|---|---|---|
| Allergens – multiple, various (including control solutions), Drops, Intradermal | Confirmation of suspected allergic reactions | Medical Practitioner | M28 |
| Allergens – multiple, various (including control solutions), Drops, Skin prick | Confirmation of suspected allergic reactions | Medical Practitioner | M19 |
| Amiloride, Tablet, Oral | Treatment of hypokalemia | Medical Practitioner | M160 |
| Betaxolol 0.25% (preservative free), Eye drops, Opthalmic | Treatment of elevated intraocular pressure where other treatments are inappropriate | Medical Practitioner | M92 |
| Bismuth subcitrate, Tablet, Oral | Treatment of resistant Helicobacter Pylori infection | Medical Practitioner | M7 |
| Buspirone, Tablet, Oral | Treatment of generalised anxiety disorders | Medical Practitioner | M17 |
| Calcitriol, Liquid, Oral | Prevention of hypophosphatemic rickets in children | Medical Practitioner | M29 |
| Calcitriol, Liquid, Oral | Treatment of hypoparathyroidism (with severe hypocalcaemia) | Medical Practitioner | M30 |
| Carbidopa, Tablet, Oral | Premedication for F‑18 DOPA imaging | Medical Practitioner | M126 |
| Ciclosporin, 0.05%, Eye drops, Emulsion, Ophthalmic | Treatment of suppressed tear production due to ocular inflammation associated with keratoconjunctivitis sicca. (dry eye syndrome) | Medical Practitioner | M12 |
| Cinnarizine, Tablet, Oral | Treatment of vestibular disorders such as vertigo, tinnitus, nausea and vomiting (including Meniere's disease) | Medical Practitioner | M13 |
| Clobetasol propionate 0.05%, Cream, Topical | Treatment, or prolongation of flare-free intervals, of dermatitis/eczema where other treatments have failed | Medical Practitioner | M94 |
| Clobetasol propionate 0.05%, Lotion, Topical | Treatment, or prolongation of flare-free intervals, of dermatitis/eczema where other treatments have failed | Medical Practitioner | M95 |
| Clobetasol propionate 0.05%, Ointment, Topical | Treatment, or prolongation of flare-free intervals, of dermatitis/eczema where other treatments have failed | Medical Practitioner | M96 |
| Clofazimine, Capsule, Oral | Treatment of drug resistant tuberculosis | Medical Practitioner | M127 |
| Clofazimine, Capsule, Oral | Treatment of non‑tuberculosis mycobacterial infections | Medical Practitioner | M128 |
| Clofazimine, Capsule, Oral | Treatment of other infections as recommended by an infectious diseases specialist | Medical Practitioner | M129 |
| Clofazimine, Capsule, Oral | Treatment of Leprosy | Medical Practitioner | M31 |
| Clofazimine, Capsule, Oral | Treatment of granulomatous cheilitis | Medical Practitioner | M32 |
| Clofazimine, Capsule, Oral | Treatment of Melkersson Rosenthal Syndrome | Medical Practitioner | M33 |
| Clofazimine, Capsule, Oral | Treatment of confirmed mycobacterium avium paratuberculosis in immunocompromised patients recommended by an infectious disease specialist | Medical Practitioner | M34 |
| Clofazimine, Capsule, Oral | Treatment of erythema nodosum leprosum | Medical Practitioner | M35 |
| Colecalciferol, Capsule, Oral | Treatment of severe vitamin D deficiency and prevention of osteoporosis | Medical Practitioner | M26 |
| Colecalciferol, Injection, Intramuscular | Treatment of severe vitamin D deficiency and prevention of osteoporosis | Medical Practitioner | M27 |
| Cyclopentolate, 0.2%, & phenylephrine, 1%, Eye drops, Ophthalmic | Production of mydriasis. | Medical Practitioner | M20 |
| Deflazacort, Tablet, Oral | Treatment of Duchenne muscular dystrophy | Medical Practitioner | M116 |
| Dehydrated ethanol (alcohol) 96% - 100%, Ampoule, Topical | Treatment of progressive keratoconus and intra-operative use in superficial keratectomy (single use per procedure) | Medical Practitioner | M36 |
| Dexamethasone (preservative free), Eye drops, Ophthalmic | Treatment of inflammatory conditions of the eye that are non‑infected and steroid responsive in patients sensitive to preservative‑containing formulations | Medical Practitioner | M130 |
| Diazoxide, Capsule, Oral | Treatment of hypoglycaemia | Medical Practitioner | M40 |
| Diazoxide, Capsule, Oral | Treatment of hyperinsulinaemia | Medical Practitioner | M41 |
| Diazoxide, Capsule, Oral | Treatment of Beckwith-Weiderman Syndrome | Medical Practitioner | M42 |
| Diazoxide, Capsule, Oral | Treatment of insulinoma | Medical Practitioner | M43 |
| Diazoxide, Suspension, Oral | Treatment of hypoglycaemia | Medical Practitioner | M44 |
| Diazoxide, Suspension, Oral | Treatment of hyperinsulinaemia | Medical Practitioner | M45 |
| Diazoxide, Suspension, Oral | Treatment of Beckwith-Weiderman Syndrome | Medical Practitioner | M46 |
| Diazoxide, Suspension, Oral | Treatment of insulinoma | Medical Practitioner | M47 |
| Diazoxide, Tablet, Oral | Treatment of hypoglycaemia | Medical Practitioner | M48 |
| Diazoxide, Tablet, Oral | Treatment of hyperinsulinaemia | Medical Practitioner | M49 |
| Diazoxide, Tablet, Oral | Treatment of Beckwith-Weiderman Syndrome | Medical Practitioner | M50 |
| Diazoxide, Tablet, Oral | Treatment of insulinoma | Medical Practitioner | M51 |
| Diflunisal, Tablet, Oral | Treatment of amyloidosis | Medical Practitioner | M97 |
| Dimethyl sulfoxide (DMSO), Solution, Intravesical | Symptomatic relief of interstitial cystitis | Medical Practitioner | M52 |
| Doxycycline, Injection, Intralesional | Sclerotherapy of lymphatic malformations | Medical Practitioner | M131 |
| Escherichia coli/klebsiella pneumoniae/enterococcus faecalis/proteus vulgaris, Spray, Sublingual | Management of recurrent urinary tract infections | Medical Practitioner | M172 |
| F-18 DCFPyl (PSMA), Injection, Intravenous | Prostate cancer imaging study | Medical Practitioner | M132 |
| F-18 myocardial perfusion trace (18F flurpiridaz), Injection, Intravenous | Myocardial perfusion study | Medical Practitioner | M121 |
| F-18 NaF (sodium fluoride), Injection, Intravenous | Bone study | Medical Practitioner | M122 |
| Flunarizine, Capsule, Oral | Prophylactic treatment of migraine | Medical Practitioner | M133 |
| Flunarizine, Capsule, Oral | Treatment of vestibular disorders | Medical Practitioner | M53 |
| Flunarizine, Tablet, Oral | Treatment of vestibular disorders | Medical Practitioner | M11 |
| Flunarizine, Tablet, Oral | Prophylactic treatment of migraine | Medical Practitioner | M134 |
| Furazolidone, Tablet, Oral | Treatment of resistant Helicobacter Pylori infection | Medical Practitioner | M23 |
| Gallium-68 DOTA (Tyr3) octreotate, Injection, Intravenous | PET imaging for localisation of somatostatin receptor positive neuroendocrine tumours (NETs) | Medical Practitioner | M166 |
| Gallium-68 (Ga-68) – MAA, Injection, Intravenous | Lung perfusion study | Medical Practitioner | M124 |
| Gallium-68 (Ga-68) Galligas, Aerosol, Inhalation | Lung ventilation study | Medical Practitioner | M123 |
| Ganciclovir, Gel, Ophthalmic | Treatment of cytomegalovirus | Medical Practitioner | M162 |
| Glycopyrronium bromide, Tablet, Oral | Treatment of excessive salivation in patients with neurological conditions | Medical Practitioner | M25 |
| Hyoscine hydrobromide, Patch, Transdermal | Treatment of excessive salivation | Medical Practitioner | M56 |
| Hypertonic sodium chloride, 5% Eye ointment, Ophthalmic | Temporary relief of corneal oedema (hypertonicity) | Medical Practitioner | M15 |
| Hypertonic sodium chloride, 5%, Eye drops, Ophthalmic | Temporary relief of corneal oedema (hypertonicity) | Medical Practitioner | M14 |
| Iloprost, Injection, Intravenous infusion | Treatment of patients with severe disabling Raynaud's phenomenon | Medical Practitioner | M153 |
| Iloprost, Injection, Intravenous infusion | Treatment of peripheral ischaemia | Medical Practitioner | M154 |
| Imipenem/cilastatin, Injection, Intravenous | Treatment of non-tuberculosis mycobacteria | Medical Practitioner | M167 |
| Indigo Carmine, Injection, Intravenous | For intraoperative detection of suspected urethral injuries during abdominal and pelvic surgical procedures | Medical Practitioner | M57 |
| Indocyanine green dye, Injection, Intravenous | For intra-operative diagnostic use | Medical Practitioner | M58 |
| Interferon Alpha-2b, Eye drops, Ophthalmic | Treatment of ocular surface squamous neoplasia | Medical Practitioner | M155 |
| Isoniazid/rifampicin, Dispersible tablets, Oral | Treatment of latent tuberculosis infection | Medical Practitioner | M168 |
| Isoniazid/rifampicin, Tablets, Oral | Treatment of latent tuberculosis infection | Medical Practitioner | M169 |
| Isoniazid/rifapentine, Tablets, Oral | Treatment of latent tuberculosis infection | Medical Practitioner | M170 |
| Ketotifen, Tablet, Oral | Treatment of allergic conditions | Medical Practitioner | M59 |
| Levofloxacin, Tablet, Oral | Treatment of drug resistant tuberculosis | Medical Practitioner | M136 |
| Levofloxacin, Tablet, Oral | Treatment of resistant Helicobacter Pylori infection | Medical Practitioner | M99 |
| Levomepromazine, Injection, Subcutaneous | Treatment of nausea and vomiting | Medical Practitioner | M102 |
| Levomepromazine, Injection, Subcutaneous | Treatment of agitation | Medical Practitioner | M103 |
| Levomepromazine, Tablet, Oral | Treatment of nausea and vomiting | Medical Practitioner | M100 |
| Levomepromazine, Tablet, Oral | Treatment of agitation | Medical Practitioner | M101 |
| Lifitegrast, Eye drops, Ophthalmic | Treatment of dry eye disease | Medical Practitioner | M156 |
| Melatonin, Lozenge, Oral | Treatment of sleep disorders | Medical Practitioner | M62 |
| Metolazone, Tablet, Oral | Treatment of fluid overload | Medical Practitioner | M163 |
| Mexiletine, Capsule, Oral | Treatment of ventricular arrhythmia | Medical Practitioner | M107 |
| Mexiletine, Capsule, Oral | Treatment of myotonic disorders | Medical Practitioner | M108 |
| Mexiletine, Tablet, Oral | Treatment of ventricular arrhythmia | Medical Practitioner | M105 |
| Mexiletine, Tablet, Oral | Treatment of myotonic disorders | Medical Practitioner | M106 |
| Moxifloxacin 0.5%, Eye drops, Ophthalmic | Treatment of refractory bacterial conjunctivitis | Medical Practitioner | M109 |
| Mycobacterium bovis (bacillus calmette and guerin (BCG) strain), Injection, Intradermal | Immunisation against tuberculosis | Medical Practitioner | M171 |
| Nadolol, Tablet, Oral | Treatment of ventricular tachycardia | Medical Practitioner | M110 |
| Nadolol, Tablet, Oral | Treatment of long QT Syndrome | Medical Practitioner | M111 |
| Natamycin 5%, Eye drops, Ophthalmic | Treatment of refractory fungal blepharitis, conjunctivitis or keratitis | Medical Practitioner | M112 |
| Neomycin, Tablet, Oral | Sepsis prevention for colorectal operation | Medical Practitioner | M137 |
| Nicotine/zero nicotine therapeutic vaping goods (incl substances, kits, and goods in vaping packs), solid/liquid, inhalation | smoking cessation or management of nicotine dependence in patients 16 years and older | Medical Practitioner, Nurse Practitioner | M164 |
| Nicotine/zero nicotine therapeutic vaping goods (incl substances, kits, and goods in vaping packs), solid/liquid, inhalation | Smoking cessation or management of nicotine dependence in patients 18 and over, concentration 20mg/mL or less | Pharmacist | M165 |
| Nitazoxanide, Suspension, Oral | Treatment of giardiasis | Medical Practitioner | M64 |
| Nitazoxanide, Suspension, Oral | Treatment of cryptosporidiosis | Medical Practitioner | M65 |
| Nitazoxanide, Suspension, Oral | Treatment of blastocystis | Medical Practitioner | M66 |
| Nitazoxanide, Tablet, Oral | Treatment of giardiasis | Medical Practitioner | M67 |
| Nitazoxanide, Tablet, Oral | Treatment of cryptosporidiosis | Medical Practitioner | M68 |
| Nitazoxanide, Tablet, Oral | Treatment of blastocystis | Medical Practitioner | M69 |
| Paromomycin, Capsule, Oral | Antiprotozoal treatment of Dientomoeba fragilis | Medical Practitioner | M71 |
| Paromomycin, Capsule, Oral | Antiprotozoal treatment of Entamoeba histolytica | Medical Practitioner | M72 |
| Paromomycin, Capsule, Oral | Antiprotozoal treatment of parasite infection | Medical Practitioner | M73 |
| Paromomycin, Capsule, Oral | Antiprotozoal treatment of Blastocystis hominis | Medical Practitioner | M70 |
| Pimozide, Tablet, Oral | Treatment of schizophrenia | Medical Practitioner | M74 |
| Pimozide, Tablet, Oral | Treatment of chronic psychosis | Medical Practitioner | M75 |
| Pimozide, Tablet, Oral | Treatment of Tourette syndrome | Medical Practitioner | M76 |
| Pristinamycin, Tablet, Oral | Treatment of confirmed methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infection where there is history of failed therapy with the other available antibiotics, at sites in relation to bone/joint/prosthesis. | Medical Practitioner | M77 |
| Pristinamycin, Tablet, Oral | Treatment of refractory or resistant mycoplasma genitalium infections | Medical Practitioner | M78 |
| Pristinamycin, Tablet, Oral | Treatment of other infections as prescribed by an infectious disease specialist | Medical Practitioner | M79 |
| Pyrazinamide, Tablet, Oral | Treatment of tuberculosis | Medical Practitioner | M22 |
| Riboflavin, 0.1% in 1.1% hydroxylpropyl methylcellulose (HPMC), Eye drops, Ophthalmic | Intraoperative use in corneal collagen crosslinking (CXL) procedures for the treatment for progressive keratoconus | Medical Practitioner | M138 |
| Riboflavin, 0.1% in 20% dextran, Eye drops, Ophthalmic | Intraoperative use in corneal collagen crosslinking (CXL) procedures for the treatment for progressive keratoconus. | Medical Practitioner | M9 |
| Riboflavin, 0.1% in sodium chloride, Eye drops, Ophthalmic | Intraoperative use in corneal collagen crosslinking (CXL) procedures for the treatment of progressive keratoconus. | Medical Practitioner | M10 |
| Riboflavin, 0.22% in sodium chloride, Eye drops, Ophthalmic | Intraoperative use in corneal collagen crosslinking (CXL) procedures for the treatment of progressive keratoconus | Medical Practitioner | M139 |
| Ripasudil 0.4%, Eye drops, Ophthalmic | Treatment of refractory corneal oedema | Medical Practitioner | M117 |
| Ripasudil 0.4%, Eye drops, Ophthalmic | Treatment of refractory gIaucoma | Medical Practitioner | M118 |
| Sodium benzoate, Tablet, Oral | Treatment of urea cycle disorders | Medical Practitioner | M113 |
| Tacrolimus 0.03%, Ointment, Topical | Treatment, or prolongation of flare-free intervals, of moderate to severe atopic dermatitis/eczema in children | Medical Practitioner | M119 |
| Tacrolimus 0.1%, Ointment, Topical | Treatment, or prolongation of flare-free intervals, of moderate to severe atopic dermatitis/eczema in adults | Medical Practitioner | M87 |
| technetium-99m (99m Tc) prostate specific membrane antigen (PSMA)-I&S, Injection, Intravenous | Prostate cancer imaging study | Medical Practitioner | M159 |
| Tetracycline, Capsule, Oral | Treatment of resistant Helicobacter Pylori infection | Medical Practitioner | M8 |
| Tetracycline, Tablet, Oral | Treatment of resistant Helicobacter Pylori infection | Medical Practitioner | M88 |
| Tick-borne Encephalitis Vaccine, Injection, Intramuscular | Prevention of tick-borne encephalitis | Medical Practitioner | M89 |
| Tinidazole, Tablet, Oral | Treatment of trichomonas vaginalis infections of the genito-urinary tract in female and male patients | Medical Practitioner | M140 |
| Tinidazole, Tablet, Oral | Treatment of giardiasis | Medical Practitioner | M141 |
| Tinidazole, Tablet, Oral | Treatment of amoebic dysentery | Medical Practitioner | M142 |
| Tinidazole, Tablet, Oral | Treatment of amoebic liver abscess | Medical Practitioner | M143 |
| Tinidazole, Tablet, Oral | Treatment of acute giardiasis in children | Medical Practitioner | M144 |
| Tinidazole, Tablet, Oral | Treatment of acute amoebic dysentery in children | Medical Practitioner | M145 |
| Tinidazole, Tablet, Oral | Treatment of amoebic liver disease in children | Medical Practitioner | M146 |
| Tinidazole, Tablet, Oral | Prevention of infection at the surgical site | Medical Practitioner | M147 |
| Tizanidine, Capsule, Oral | Treatment of spasticity where other treatments have failed | Medical Practitioner | M114 |
| Tizanidine, Tablet, Oral | Treatment of spasticity where other treatments have failed | Medical Practitioner | M115 |
| Triamcinolone acetonide, Suspension for Injection, Ophthalmic | Treatment of non-infectious uveitis | Medical Practitioner | M120 |
| Triamcinolone acetonide, Suspension for Injection, Ophthalmic | Treatment of diabetic macular oedema | Medical Practitioner | M148 |
| Triamcinolone acetonide, Suspension for Injection, Ophthalmic | Treatment of cystoid macular oedema secondary to retinal vein occlusion | Medical Practitioner | M149 |
| Triamcinolone acetonide, Suspension for Injection, Ophthalmic | Treatment of uveitic macular oedema | Medical Practitioner | M150 |
| Triamcinolone acetonide, Suspension for Injection, Ophthalmic | Treatment of post‑operative macular oedema (cataract surgery) | Medical Practitioner | M151 |
| Triamcinolone acetonide, Suspension for Injection, Ophthalmic | Visualisation during vitrectomy | Medical Practitioner | M2 |
| Verteporfin Powder for injection, Intravenous infusion | Photosensitisation for photodynamic therapy | Medical Practitioner | M21 |
| Yttrium-90 (Y-90) citrate, Injection, Intraarticular | Radiosynovectomy treatment | Medical Practitioner | M90 |
Biologicals
| Product name, active ingredient, route of administration | Indication | Practitioner type | Code |
|---|---|---|---|
| Amniotic Membrane, Ophthalmic | Ocular conditions | Medical Practitioner | B30 |
| Ortho-ATI (tenocytes), cell suspension | Treatment of chronic lateral epicondylitis or gluteal tendinopathy (> 6 months) with or without partial tendon tear, that is not responsive to conservative treatment.” | Orthopaedic Surgeon | B56 |
| Tutoplast Pericardium (sterilised human tissue allograft), Topical | Soft tissue graft | Medical Practitioner | B29 |
Medical devices
| Product name, manufacturer name, description (including manufacturer’s intended purpose and any variant details) | Purpose | Practitioner type | Code |
|---|---|---|---|
| 14/16 Taper Femoral Heads – Oxinium, Smith & Nephew (Catalogue no: 71342280 to 71342368) | Revision hip arthroplasty | Orthopaedic Surgeon | D28 |
| AltiVate Reverse Shoulder system- DJO Global | For arthroplasty of the shoulder | Orthopaedic Surgeon | D49 |
| CelGro Type I/III collagen scaffold, Orthocell | Articular cartilage repair: Collagen scaffold for use with autologous chondrocyte implantation (ACI) to knee (including patellofemoral) and ankle joint | Orthopaedic Surgeon | D32 |
| CelGro Type I/III collagen scaffold, Orthocell | Augmentation of rotator cuff tendon repair | Orthopaedic Surgeon | D33 |
| CollaCote Dressing | For haemostasis | Dental Practitioner | D7 |
| CollaCote Dressing | To protect the wound surface during dental procedures | Dental Practitioner | D24 |
| CollaPlug Absorbable Collagen Wound Dressing | For haemostasis | Dental Practitioner | D8 |
| CollaPlug Absorbable Collagen Wound Dressing | To protect the wound surface during dental procedures | Dental Practitioner | D25 |
| CollaTape Absorbable Collagen | For haemostasis | Dental Practitioner | D9 |
| CollaTape Absorbable Collagen | To protect the wound surface during dental procedures | Dental Practitioner | D26 |
| Duraloc Acetabular Cup System – Hip Insert/Liner – Johnson & Johnson t/a DePuy Synthes | Revision hip arthroplasty | Orthopaedic Surgeon | D50 |
| Endotine Forehead | For use in subperiosteal browplasty surgery | Ophthalmologist, Plastic Surgeon | D14 |
| Endotine Midface | For use in subperiosteal midface suspension surgery | Plastic Surgeon | D15 |
| Insall/Burstein II Modular Knee System - Posterior Stabilised Tibial Articular Surface, Zimmer Biomet (Catalogue no: 00522003101 to 00522003506) | Revision knee arthroplasty | Orthopaedic Surgeon | D35 |
| MG II Total Knee System - Tibial Articular Surface, Zimmer Biomet (Catalogue no: 00511002309 to 00511005323) | Revision knee arthroplasty | Orthopaedic Surgeon | D38 |
| M/G Unicompartmental Knee System - Tibial Articulating Surface, Zimmer Biomet (Catalogue no: 00578804008 to 00578808014) | Revision knee arthroplasty | Orthopaedic Surgeon | D39 |
| Natural Knee II System – Durasul PE Congruent Tibial Insert, Zimmer Biomet (Catalogue no: 620108809 to 620110916) | Revision knee arthroplasty | Orthopaedic Surgeon | D40 |
| NexGen Complete Knee Solution – Cruciate Retaining (CR) Articular Surface, Zimmer Biomet (Catalogue no: 00597002009 to 00597005020) | Revision knee arthroplasty | Orthopaedic Surgeon | D41 |
| NexGen Complete Knee Solution Legacy PS - Articular Surface, Zimmer Biomet (Catalogue no: 5996-020-09 to 00-5996-022-23 AND 00-5996-030-09 to 00-5996-051-20) | Revision knee arthroplasty | Orthopaedic Surgeon | D42 |
| NexGen Complete Knee Solution Mobile Bearing Knee System - Articular Surface, Zimmer Biomet (Catalogue no: 00594203109 to 00594207217) | Revision knee arthroplasty | Orthopaedic Surgeon | D43 |
| NexGen Complete Knee Solution – Posterior Stabilized (PS) Articular Surface, Zimmer Biomet (Catalogue no: 00598202010 to 00598205123) | Revision knee arthroplasty | Orthopaedic Surgeon | D44 |
| Omnifit Crossfire Series II Cup Insert, Stryker Orthopaedics (Catalogue no: 2041C2240 to 2041C3274) | Revision hip arthroplasty | Orthopaedic Surgeon | D45 |
| Origin Stem, Coxa Vara, Sizes 9 to 18, Signature Orthopaedics | Hip arthroplasty | Orthopaedic Surgeon | D53 |
| Primetech Piezo Micro Manipulator and microinjection pipettes | In vitro fertilisation | Obstetrics and Gynaecology Specialist | D51 |
| Pro Osteon® Bone Graft Substitute 200R | For use as a bone graft substitute only for bony voids or gaps that are not intrinsic to the stability of the bony structure | Medical Practitioner; Dental Practitioner | D20 |
| Pro Osteon® Bone Graft Substitute 500R | For use as a bone graft substitute only for voids or gaps that are not intrinsic to the stability of the bony structure | Medical Practitioner | D21 |
| Quintip Individual Skin Test System | For allergy skin testing using puncture to apply the test extract | Medical Practitioner | D22 |
| Reflection Ceramic Acetabular System - Reflection Biolox Forte Ceramic Acetabular Liner, Smith & Nephew (Catalogue no: 71338146 to 71338456) | Revision hip arthroplasty | Orthopaedic Surgeon | D46 |
| Regeneten Bioinductive Implant – Bone Anchors with Anthroscopic Delivery System | Rotator cuff surgery | Orthopaedic Surgeon | D52 |
| SeleXys Hip System – Inlay Bionit2 - Mathys Orthopaedics (Catalogue no: 55462803 to 55463612) | Revision hip arthroplasty | Orthopaedic Surgeon | D47 |
| Taurolock-U25,000 ((cyclo)-taurolidine, citrate (4%) and urokinase (25,000 IU)) | For use as a catheter lock solution, instilled into a port or a silicone or polyurethane catheter based device at the termination of a treatment, and is withdrawn prior to subsequent treatments | Nephrology physician | D54 |
| Trilogy AB Alternate Bearing Shell Insert, Zimmer Biomet (Catalogue no: 00640502601 to 00640503206 AND 00641502802 to 00641503206) | Revision hip arthroplasty | Orthopaedic Surgeon | D48 |